Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...
Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
The Royal Hospital, Muscat, Muscat, Mucsat, Oman
Department of Anesthesiology, West China Hospital, Chengdu, Sichuan, China
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Oregon Health & Science University, Portland, Oregon, United States
Assiut University, Assiut, Egypt
University of Kansas Cancer Center, Kansas City, Kansas, United States
Syed Muhammad Abbas, Karachi, Sindh, Pakistan
Medical University of Innsbruck, Innsbruck, Austria
Medical University of Vienna, Vienna, Austria
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.